Fresenius Medical Care is the world's largest fully integrated provider of products and services for individuals undergoing dialysis due to chronic kidney failure. Through its network of more than 3,000 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatments for 250,000 patients around the globe.
Building on the experience in the field of dialysis, Fresenius Medical Care (FME) has additionally embarked on providing products and services in the field of Therapeutic Apheresis, a specialized division that is dedicated to service extracorporeal treatments to patients in whom standard therapy approaches have unfortunately failed.
In this context, FME offers products for selective and semi-selective cleaning of wholeblood and plasma. For instance, Immunosorba® and GLOBAFFIN® from Fresenius Medical Care are two specific adsorber columns for the treatment of Immunogobuline “G” mediated diseases. These regenerable columns allow multiple applications within the plasma and are mainly used for the treatment of autoimmune diseases and antibody mediated transplant rejections (e.g. dilated cardiomyopathy, pemphigus vulgaris, myasthenia gravis, acute humoral rejection, etc.). In addition, single use adsorbers for immunglobuline G and E will complement the therapeutic offer in the field of selective antibody depletion.
But also genetically impaired high levels of blood cholesterol are a typical indication for Therapeutic Apheresis. In patients suffering from severe hypercholesterolaemia, the only effective therapy option to reduce LDL-C and Lp(a) significantly is the lipoprotein apheresis technology with e.g. the apheresis wholeblood adsorber DALI® or double filtration system MONET® for plasma treatments.
FME`s proprietary machine portfolio provides a suitable platform for all adsorber & filters and thus offers a broad spectrum of reliable therapy solutions.
FME continues in its research ambitions to deliver novel approaches and products in this challenging field of Therapeutic Apheresis and is dedicated to support patients with best available services and care.
Company Website : http://www.freseniusmedicalcare.com/en/home/
For members
International Society For Apheresis
Postcode: 520-2192
Shiga University of Medical Science,
Seta Tsukinowa-cho, Otsu,
Shiga 520-2192, Japan
 |
International Society For Apheresis ISFA Headquarters Shiga University of Medical Science
|
